Gender-based Violence and HIV Testing and
Counseling in Kenya
Couples HIV testing and counseling (CHTC) is a core intervention for identifying sero-discordant couples for both treatment and prevention interventions and is correlated with positive outcomes for both partners. Currently, CHTC has been introduced in different modalities and settings and is being expanded in many sub-Saharan African countries. However, it also poses risks for specific populations with respect to possible unintended negative outcomes, including gender-based violence (GBV). Similarly, violence and fear of violence are often cited as barriers to HIV testing and disclosing a positive test result. While there are a number of tools and resources regarding integration of GBV in HIV interventions generally, there are few or none specifically designed for the HTC context. This study will review and modify available tools to develop an intervention that integrates GBV/intimate partner violence (IPV) issues in the HTC context and enables providers to become more sensitive to GBV/IPV and raise, screen and discuss this issue with clients, and refer them appropriately. HIVCore will then pilot the intervention in the antenatal care setting to gather 1) primarily process data, specifically, on providers’ experience, and clients’ reports of the actual counseling experience; and 2) on an exploratory basis gather data on intermediate outcomes including, women’s knowledge about IPV, referral for IPV services for those screening positive for IPV, sense of agency related to decisions around uptake of services and perception that they have received meaningful support and counsel. The study responds to discussions in the field regarding how best to address IPV in the HTC/CHTC context.
To learn more about this study, please contact us at firstname.lastname@example.org.
HIVCore has published a new report!
Retaining pregnant and lactating women in PMTCT programs is a critical element in the cascade in order to eliminate new HIV infections among children. However, there are limited data on current retention rates as well as drug adherence. Read about HIVCore’s secondary data analysis in selected countries to assess the extent of and factors associated with retention among women and infants in the PMTCT program and the challenges in extracting this data.
Will you be at the 14th World Congress in Public Health in Calcutta, India next week? HIVCore researcher Adam Granato will be giving two oral presentations on the Cote d'Ivoire PMTCT Cascade Secondary Analysis Phase I study. (More information about study and presentation times.)
If you are at Afri-Can Forum-2 (Johannesburg, South Africa; 16-18 February 2015), Stephen Okoboi (TASO-Uganda) will be presenting on the Uganda Adolescent HAART Retention study. (More information about study and presentation times.)
Several studies are now underway. Go to our “Key Activities” page to learn more.
To ensure you are among the first to know the latest from HIVCore and receive future editions of the newsletter, please send an e-mail with “SUBSCRIBE” in the subject line to email@example.com.